HIV/AIDS Experts & Viewpoints
- Why Should I Report an Adverse Drug Event?
- When Your Patients and In-laws Ask Whether They Should Receive the Shingles Vaccine
- Retooling for an Aging America
- Physicians for Sale: How Medical Professional Organizations Exploit Their Members
- Building Physician Connectivity for e-Prescribing
- A Reply to Thomas Stossel on the AMA-CEJA Draft Report
- Diagnosis, Treatment, and Management of CDI: An Expert Interview With Cassandra D. Salgado, MD, MS
- Response to AMA's Council on Ethical and Judicial Affairs Draft Report on "Ethical Guidance for Physicians and the Profession With Respect to Industry Support for Professional Education in Medicine"
- Let's Get Real About Conflicts of Interest in Medicine
- Daily Tadalafil Prevents Erectile Dysfunction in Diabetic Men
POLL
A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?